Lantern Pharma LTRN Q1 2026 Earnings EPS Beats Estimates by 183 Despite Absence of Revenue RDDT Q1 2026 Earnings EPS Blowout Surprises Wall Street Yet Shares Slide CBRL Q1 2026 Earnings Significant EPS Beat Surprises Market MAPS Q1 2026 Earnings EPS Miss Weighs on Shares Despite Narrow Profit Beyond Air Inc XAIR Q1 2026 Earnings Narrowing Losses but Revenue Remains Absent China Pharma Holdings CPHI Q3 2011 Earnings EPS Miss Weighs on Sentiment Apartment Investment and Management Company AIV Q3 2024 Earnings FFO Miss Raises Questions Amid Portfolio Transition MMI Q1 2026 Earnings EPS Misses Estimates Amid Challenging Market GCMG Q1 2026 Earnings EPS Misses Estimates Amid Cautious Outlook QuinStreet Q1 2026 Earnings EPS Misses Estimates but Stock Rises on Operational Progress BioMarin Q1 2026 Earnings EPS Misses Estimates as Stock Slips PROV Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher GLXY Q1 2026 Earnings EPS Misses Estimates as Loss Widens Stock Climbs 648 Despite Disappointment